Quantinno Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$195K Buy
40,452
+26,095
+182% +$158K ﹤0.01% 3346
2026
Q1
$88.4K Sell
14,357
-8,450
-37% -$70.2K ﹤0.01% 3265
2025
Q4
$238K Buy
22,807
+4,642
+26% +$46.6K ﹤0.01% 2969
2025
Q3
$163K Buy
18,165
+8,165
+82% +$71.7K ﹤0.01% 2812
2025
Q2
$130K Buy
+10,000
New +$150K ﹤0.01% 2462

Other funds holding RXST

Quantinno Capital Management's RXST Position: Q2 2026 in Review

Quantinno Capital Management increased its RxSight (RXST) stake by 182% in Q2 2026, buying an estimated $158K and bringing the position to 40,452 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Quantinno Capital Management first reported a position in RXST in Q2 2025 and has held it in 5 quarters since. The position peaked at $238K in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Quantinno Capital Management held 40,452 shares of RxSight worth $195K as of Q2 2026.
  • Quantinno Capital Management bought 26,095 RxSight shares in Q2 2026, an estimated $158K.
  • RxSight made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3346 holding.
  • Quantinno Capital Management first reported a position in RxSight in Q2 2025 and has held it in 5 quarters since.
  • Quantinno Capital Management's RxSight position peaked at $238K in Q4 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.